XBIO · Xenetic Biosciences Inc
United States · RS rating 25 · As of 2026-11-03
| Price | 2.08 USD |
|---|---|
| 1-day change | +1.0% |
| RS rating (overall / 1M / 3M / 12M) | 25 / 44 / 21 / 27 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 19 / 18 / 19 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -105.0% |
| Sales growth Q/Q | -25.4% |
| Distance from 52-week high | +55.5% |
| Market cap (USD) | $7.2M |